Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling

Angiogenesis

Volumn 17, Issue 3, 2014, Pages 573-585

  Rego, Stephen L ^a   Helms, Rachel S ^a   Dréau, Didier ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Breast cancer; CCL2; Macrophage colony stimulating factor; Tumor associated macrophages; Tumor necrosis factor alpha converting enzyme

Indexed keywords

BAY 11 7083; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TAPI 0; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; ADAM PROTEIN; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; BREAST CANCER CELL LINE; BREAST EPITHELIUM; BREAST TUMOR; CARCINOMA CELL; CELLULAR SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; INTRACELLULAR SIGNALING; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VASCULARIZATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; EPITHELIUM CELL; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; MACROPHAGE; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

MURINAE; MUS;

ADAM PROTEINS; ANIMALS; CELL LINE, TUMOR; CHEMOKINE CCL2; EPITHELIAL CELLS; FEMALE; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84903886503     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9405-2     Document Type: Article

References (60)

1. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20):1584-1598. doi: 10.1093/jnci/djq366
2. American Cancer Society (2013) Cancer Facts and Figures 2013. American Cancer Society, Atlanta
3. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674. doi: 10.1016/j.cell.2011.02.013
4. Lin EY, Pollard JW (2004) Macrophages: modulators of breast cancer progression. Novartis Found Symp 256:158-168 discussion 168-172, 259-169
5. Kelly PM, Davison RS, Bliss E, McGee JO (1988) Macrophages in human breast disease: a quantitative immunohistochemical study. Br J Cancer 57(2):174-177
6. Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23(4):344-346. doi: 10.1016/j.immuni.2005.10.001
7. Pollard JW (2008) Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 84(3):623-630. doi: 10.1189/jlb.1107762
8. Sica A, Bronte V (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117(5):1155-1166. doi: 10.1172/JCI31422
9. Arribas J, Esselens C (2009) ADAM17 as a therapeutic target in multiple diseases. Curr Pharm Des 15(20):2319-2335
10. Kenny PA, Bissell MJ (2007) Targeting TACE-dependent EGFR ligand shedding in breast cancer. J Clin Invest 117(2):337-345. doi: 10.1172/JCI29518
11. Horiuchi K, Miyamoto T, Takaishi H, Hakozaki A, Kosaki N, Miyauchi Y, Furukawa M, Takito J, Kaneko H, Matsuzaki K, Morioka H, Blobel CP, Toyama Y (2007) Cell surface colony-stimulating factor 1 can be cleaved by TNF-α converting enzyme or endocytosed in a clathrin-dependent manner. J Immunol 179(10):6715-6724
12. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385(6618):729-733. doi: 10.1038/385729a0
13. Lee DC, Sunnarborg SW, Hinkle CL, Myers TJ, Stevenson MY, Russell WE, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Chang A, Jackson LF (2003) TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann N Y Acad Sci 995:22-38
14. Tsakadze NL, Sithu SD, Sen U, English WR, Murphy G, D'Souza SE (2006) Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J Biol Chem 281(6):3157-3164. doi: 10.1074/jbc.M510797200
15. Dovas A, Patsialou A, Harney AS, Condeelis J, Cox D (2012) Imaging interactions between macrophages and tumour cells that are involved in metastasis in vivo and in vitro. J Microsc. doi: 10.1111/j.1365-2818.2012.03667. x
16. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475(7355):222-225. doi: 10.1038/nature10138
17. Low-Marchelli JM, Ardi VC, Vizcarra EA, van Rooijen N, Quigley JP, Yang J (2013) Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res 73(2):662-671. doi: 10.1158/0008-5472.CAN-12-0653
18. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549-555
19. Kluger HM, Dolled-Filhart M, Rodov S, Kacinski BM, Camp RL, Rimm DL (2004) Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clin Cancer Res 10(1 Pt 1):173-177
20. Scholl SM, Lidereau R, de la Rochefordiere A, Le-Nir CC, Mosseri V, Nogues C, Pouillart P, Stanley FR (1996) Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study. Breast Cancer Res Treat 39(3):275-283
21. Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW, Condeelis J (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67(6):2649-2656. doi: 10.1158/0008-5472.CAN-06-1823
22. Curry JM, Eubank TD, Roberts RD, Wang Y, Pore N, Maity A, Marsh CB (2008) M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS ONE 3(10):e3405. doi: 10.1371/journal.pone.0003405
23. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66(23):11238-11246. doi: 10.1158/0008-5472.CAN-06- 1278
24. McDougall SR, Anderson AR, Chaplain MA (2006) Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol 241(3):564-589. doi: 10.1016/j.jtbi.2005.12.022
25. Weigand M, Hantel P, Kreienberg R, Waltenberger J (2005) Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis 8(3):197-204. doi: 10.1007/s10456-005-9010-0
26. Rugo HS (2004) Bevacizumab in the treatment of breast cancer: rationale and current data. Oncologist 9(Suppl 1):43-49
27. Cohen MH, Gootenberg J, Keegan P, Pazdur R (2007) FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. Oncologist 12(3):356-361. doi: 10.1634/theoncologist.12-3-356
28. Brufsky AM, Hurvitz S, Perez E, Swamy R, Valero V, O'Neill V, Rugo HS (2011) RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. J Clin Oncol 29(32):4286-4293. doi: 10.1200/JCO.2010.34.1255
29. Kiriakidis S, Andreakos E, Monaco C, Foxwell B, Feldmann M, Paleolog E (2003) VEGF expression in human macrophages is NF-κB-dependent: studies using adenoviruses expressing the endogenous NF-κB inhibitor IκBα and a kinase-defective form of the IκB kinase 2. J Cell Sci 116(Pt 4):665-674
30. Wang Y, Mo X, Piper MG, Wang H, Parinandi NL, Guttridge D, Marsh CB (2011) M-CSF induces monocyte survival by activating NF-κB p65 phosphorylation at Ser276 via protein kinase C. PLoS ONE 6(12):e28081. doi: 10.1371/journal.pone.0028081
31. Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-κB signaling pathways. Nat Immunol 12(8):695-708. doi: 10.1038/ni.2065
32. Wang G, Chen C, Yang R, Cao X, Lai S, Luo X, Feng Y, Xia X, Gong J, Hu J (2013) p55PIK-PI3K stimulates angiogenesis in colorectal cancer cell by activating NF-κB pathway. Angiogenesis. doi: 10.1007/s10456-013-9336-y
33. Karin M (2006) Nuclear factor-κB in cancer development and progression. Nature 441(7092):431-436. doi: 10.1038/nature04870
34. Maxson S, Burg KJ (2008) Conditioned media cause increases in select osteogenic and adipogenic differentiation markers in mesenchymal stem cell cultures. J Tissue Eng Regen Med 2(2-3):147-154. doi: 10.1002/term.76
35. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 181(8):5791-5802
36. Swamydas M, Nguyen D, Allen LD, Eddy J, Dreau D (2011) Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells. Cell Commun Adhes 18(6):119-130. doi: 10.3109/15419061.2011.641042
37. Rego SL, Swamydas M, Kidiyoor A, Helms R, De Piante A, Lance AL, Mukherjee P, Dreau D (2013) Soluble tumor necrosis factor receptors shed by breast tumor cells inhibit macrophage chemotaxis. J Interferon Cytokine Res. doi: 10.1089/jir.2013.0009
38. Arnaoutova I, Kleinman HK (2010) In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5(4):628-635. doi: 10.1038/nprot.2010.6
39. Arnaoutova I, George J, Kleinman HK, Benton G (2009) The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12(3):267-274. doi: 10.1007/s10456-009-9146-4
40. Lewis JS, Landers RJ, Underwood JC, Harris AL, Lewis CE (2000) Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 192(2):150-158. doi: 10.1002/1096-9896(2000)9999:9999<:AID-PATH687>3.0.CO;2-G
41. Lance A, Yang CC, Swamydas M, Dean D, Deitch S, Burg KJ, Dreau D (2013) Increased extracellular matrix density decreases MCF10A breast cell acinus formation in 3D culture conditions. J Tissue Eng Regen Med. doi: 10.1002/term.1675
42. Swamydas M, Eddy JM, Burg KJ, Dreau D (2010) Matrix compositions and the development of breast acini and ducts in 3D cultures. Vitro Cell Dev Biol Anim 46(8):673-684. doi: 10.1007/s11626-010-9323-1
43. Lin CW, Shen SC, Ko CH, Lin HY, Chen YC (2010) Reciprocal activation of macrophages and breast carcinoma cells by nitric oxide and colony-stimulating factor-1. Carcinogenesis 31(12):2039-2048. doi: 10.1093/carcin/bgq172
44. Bohrer LR, Schwertfeger KL (2012) Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner. Mol Cancer Res 10(10):1294-1305. doi: 10.1158/1541-7786.MCR-12-0275
45. Bingle L, Lewis CE, Corke KP, Reed MW, Brown NJ (2006) Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94(1):101-107. doi: 10.1038/sj.bjc.6602901
46. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2(5):561-566
47. McGowan PM, Ryan BM, Hill AD, McDermott E, O'Higgins N, Duffy MJ (2007) ADAM-17 expression in breast cancer correlates with variables of tumor progression. Clin Cancer Res 13(8):2335-2343. doi: 10.1158/1078-0432.CCR-06-2092
48. Trad A, Riese M, Shomali M, Hedeman N, Effenberger T, Grotzinger J, Lorenzen I (2013) The disintegrin domain of ADAM17 antagonises fibroblastcarcinoma cell interactions. Int J Oncol 42(5):1793-1800. doi: 10.3892/ijo 2013.1864
49. Zheng Y, Schlondorff J, Blobel CP (2002) Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J Biol Chem 277(45):42463-42470. doi: 10.1074/jbc.M207459200
50. Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB (2009) The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res 15(3):778-787. doi: 10.1158/1078-0432.CCR-08-1283
51. Hamilton JA (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8(7):533-544. doi: 10.1038/nri2356
52. Eubank TD, Galloway M, Montague CM, Waldman WJ, Marsh CB (2003) M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J Immunol 171(5):2637-2643
53. Biswas SK, Lewis CE (2010) NF-κB as a central regulator of macrophage function in tumors. J Leukoc Biol 88(5):877-884. doi: 10.1189/jlb.0310153
54. Hagemann T, Biswas SK, Lawrence T, Sica A, Lewis CE (2009) Regulation of macrophage function in tumors: the multifaceted role of NF-κB. Blood 113(14):3139-3146. doi: 10.1182/blood-2008-12-172825
55. Karin M, Greten FR (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749-759. doi: 10.1038/nri1703
56. Gray MJ, Poljakovic M, Kepka-Lenhart D, Morris SM Jr (2005) Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPβ. Gene 353(1):98-106. doi: 10.1016/j.gene.2005.04.004
57. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ (2000) Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 14(13):2055-2064. doi: 10.1096/fj.99-0963com
58. Varney ML, Olsen KJ, Mosley RL, Singh RK (2005) Paracrine regulation of vascular endothelial growth factor - a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J Interferon Cytokine Res 25(11):674-683. doi: 10.1089/jir.2005.25.674
59. Kim KB, Sosman JA, Fruehauf JP, Linette GP, Markovic SN, McDermott DF, Weber JS, Nguyen H, Cheverton P, Chen D, Peterson AC, Carson WE 3rd, O'Day SJ (2012) BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma. J Clin Oncol 30(1):34-41. doi: 10.1200/JCO.2011.34. 6270
60. Rego SL, Helms RS, Dréau D (2013) Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer. Immunol Res. doi: 10.1007/s12026-013-8434-7